Here are relevant reports on : prostate-cancer-diagnostics-market
-
Global Colorectal Cancer Market (2010-2015)
2008 saw almost 12 million patients diagnosed with cancer. Despite, increasing technological advancements and research the deaths due to cancer were about 8 million people in 2008. Lung cancer accounts for the highest mortality rate.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Lung Cancer Therapeutics Market (NSCLC & SCLC) - 2010-2020 (Pipeline Assessment and Market Forecast) in G7 countries
Lung cancer is responsible for most of the deaths (due to cancer) across the globe. With just one drug slated to be launched by 2014 – Talactoferrin by Agennix AG, for patients with advanced lung cancer; having failed both chemotherapy and treatments with epidermal growth factor receptor (EFGR) - Tyrosine kinase inhibitor (TKI). Lung cancer is still an area with high unmet need for early diagnosis and limited treatment options in the advanced stages of lung cancer.
- Published: November 2011
- Price: $ 4950
- TOC Available:
-
ECU Diagnostics and Testing Market - Global Forecast to 2032
The ECU diagnostics and testing market is projected to grow from USD 18.0 billion in 2025 to reach USD 28.6 billion by 2032. Increasing popularity of hybrid & electric vehicles with complex electrical architectures, increase in demand for advanced features such as ADAS systems for vehicle safety, and rise in demand for in-vehicle experience with entertainment in the vehicle is driving the demand for ECU diagnostics and Testing market during the forecast period.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Companion Diagnostics Market - 2019 By Types, Application & Geography
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Epigenetic Drugs & Diagnostics Market - Global Forecast to 2030
Epigenetic Drugs & Diagnostics Market
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Image-Guided Radiation Therapy Market by Product (4D RT, LINAC, MRI-guided radiotherapy, Portal CT Imaging), Procedure (IMRT, Stereotactic, Particle), Application (Neck, Prostate, Breast cancer), End User (Hospital, ACC) & Region - Global Forecast to 2028
The global image-guided radiation therapy market, valued at US$1.8 billion in 2022, stood at US$1.9 billion in 2023 and is projected to advance at a resilient CAGR of 5.2% from 2023 to 2028, culminating in a forecasted valuation of US$2.4 billion by the end of the period. Rising demand for image-guided interventions and growth in non-invasive treatments of cancer management are a few drivers that collectively contribute to the growth of the image-guided radiation therapy market, and as healthcare technologies continue to evolve, the demand for image-guided radiation therapy is expected to rise further in the upcoming years.
- Published: September 2023
- Price: $ 4950
- TOC Available:
-
Fiducial Markers Market by Product (Metal Based Markers (Gold, Gold Combination) Polymer Markers), Cancer Type (Prostate, Lung, Breast), Modality (CT, CBCT, MRI, Ultrasound), End User (Hospitals, Outpatient Facilities) & Region - Global Forecast to 2025
The global fiducial markers market growth is primed to transition from $95 million in 2019 to $123 million by 2025, showcasing a strong CAGR of 4.5%. Increasing investments, funds, and grants by public-private organizations for cancer research, technological advancements in the market, and the rising cancer burden globally will fuel market growth over the forecast period.
- Published: February 2020
- Price: $ 4950
- TOC Available:
-
Radiotherapy Market by Technology (EBRT:MR LINAC, Stereotactic, Particle; IBRT/Brachytherapy, Cobalt-60 Teletherapy), Procedure (IGRT, IMRT, 3D-CRT, HDR, LDR, PDR), Cancer (Prostate, Breast, Lung, CRC), End User (Hospital, IRC) - Global Forecasts to 2030
The global radiotherapy market, valued at US$6.23 billion in 2022, stood at US$7.21 billion in 2024 and is projected to advance at a resilient CAGR of 4.9% from 2024 to 2030, culminating in a forecasted valuation of US$9.62 billion by the end of the period. During the forecast years, the growth of the market is attributed to the focus on advancements in radiotherapy treatment technology growing patient population, increasing initiatives to promote radiotherapy awareness.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Artificial Intelligence (AI) in Medical Imaging Market by Component(Hardware, Software, Service), Modality (MRI, CT, X-Ray), Application (Radiology, Cardio, Cancer- Lung, Breast, Prostate), End User(Hospital, Imaging Center) - Global Forecast to 2029
The global artificial Intelligence (AI) in medical imaging market, valued at US$1.29 billion in 2023, stood at US$1.65 billion in 2024 and is projected to advance at a resilient CAGR of 22.4% from 2024 to 2029, culminating in a forecasted valuation of US$4.54 billion by the end of the period. The factors driving the market growth include increasing government initiatives on AI-based technologies, higher funding for AI startups, a massive inflow of big data, and growing cross-industry collaborations.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Liquid Biopsy Market by Product & Service (Kits, Instruments), Circulating Biomarker (ctDNA, cfDNA, CTC), Technology (NGS, PCR), Application (Lung, Breast, Prostate Cancer), Sample Type (Blood, Urine, CSF), End User (Hospitals) - Global Forecast to 2030
The global liquid biopsy market, valued at US$3.65 billion in 2024, stood at US$4.03 billion in 2025 and is projected to advance at a resilient CAGR of 11.8% from 2025 to 2030, culminating in a forecasted valuation of US$7.05 billion by the end of the period. The increasing global cancer incidence and the growing emphasis on early and precise disease detection primarily drive this market expansion.
- Published: July 2025
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
